Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2026-04-02 @ 12:21 PM
Study NCT ID:
NCT07115095
Status:
COMPLETED
Last Update Posted:
2025-08-11
First Post:
2025-07-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer
Sponsor:
Nanlin Li
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
KY20202039-C-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None